Nearly 95 per cent of people with cancer developed a good immune response to the Covid-19 mRNA vaccines three to four weeks after receiving their second dose, finds a new study co-authored by Indian-origin researchers.
The study, published in the journal Cancer Cell, indicated that among the 131 patients studied, 94 per cent developed antibodies to the coronavirus.
Seven high-risk patients did not.
"We could not find any antibodies against the virus in those patients," said researcher Dimpy P. Shah from the University Of Texas Health Science Center at San Antonio.
Among the high-risk groups, patients receiving a therapy called Rituximab within six months of vaccination developed no antibodies. Rituximab is a monoclonal antibody used in the treatment of hematological cancers and autoimmune diseases.
Patients on chemotherapy that is toxic to cells developed antibody response, but it was muted compared to the general population.
"How that relates to protection against COVID-19, we don't know yet," Dimpy Shah said.
The Delta variant and other mutants of the Covid-19 virus were not examined in the study. The team also did not analyze the response of infection-fighting T cells and B cells in patients with cancer.
"Patients with hematological malignancies, such as myeloma and Hodgkin lymphoma, were less likely to respond to vaccination than those with solid tumours," said Pankil K. Shah from the Geneva University Hospital.
The median age of patients in the study was 63. Most of the patients (106) had solid cancers as opposed to hematological malignancies (25).
Govt slashes prices of 41 medicines
Antacids, multivitamins, and antibiotics are among the medicines that will become cheaper, according to a notification issued by the Department of Pharmaceuticals and National Pharmaceutical Pricing Authority (NPPA).
At least 1 in 5 new mothers experiences postpartum depression: Doctors
While parenthood comes as a blessing for many, for more than 20 per cent of mothers, the new chapter of life creates stress, anxiety and postpartum depression, which can turn fatal for both the mother and child, without adequate support, said doctors on Mother’s Day on Sunday.
New immunotherapy to fight cancer, keep healthy cells safe
A team of US researchers has developed a new immunotherapy technique that uses cytokine proteins as a potential treatment, effectively targeting tumours without causing harm to healthy cells.
Why excess sugar, oil are as dangerous for liver as alcohol
While alcohol is known to be bad for liver health, consuming foods rich in sugar and oil may be equally dangerous for the organ as well as for overall health, said doctors on Thursday, ahead of World Liver Day.
Lungs of young adults more susceptible to SARS-CoV-2 virus: Study
While older age has been associated with an increased risk of SARS-CoV-2, the virus responsible for Covid-19, a new study has revealed that the lungs of young adults are more susceptible to the virus.
Congress in Tripura blocks rail stations to protest police fired-killing of 5 farmers in MP
The firing on Tuesday came during raucous protests to demand better crop prices in the drought-ravaged region that saw one farmer suicide every five hours in the past two years.
DMs, SPs of violence-hit MP districts transferred
The farmers agitation entered its eighth day on Thursday. The peasants have been on strike since June 1, demanding loan waiver and fair price for their produce.
Indian American selected among 12 NASA astronaut candidates
He continued on to earn a master's degree in aeronautics and astronautics from Massachusetts Institute of Technology and graduated from the US Naval Test Pilot School.